Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Testing for BRCA1 mutations: a cost-effectiveness analysis.

European journal of human genetics : EJHG - 1 Oct 2002

Sevilla Christine, Moatti Jean-Paul, Julian-Reynier Claire, Eisinger François, Stoppa-Lyonnet Dominique, Bressac-de Paillerets Brigitte, Sobol Hagay

Abstract excerpt

Breast carcinoma is the most common type of cancer affecting women in the Western world. The hereditary forms, which amount from 5 to 10% of all the cases of breast cancer, mainly involve BRCA1 or BRCA2 mutations. Due to the diagnostic strategy used by the patent owner, Direct DNA sequencing (DS) may become the only BRCA1/2 test procedure available, although there exist several alternative strategies. A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to BRCA1 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 gene

Share to Genes, BRCA1

Share to Genetic Testing

Share to Mutation

Share to Sequence Analysis, DNA

Source

Identifiers

PMID: 12357330
DOI: 10.1038/sj.ejhg.5200854

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Testing for BRCA1 mutations: a cost-effectiveness analysis.PMID 12357330Read ↗

Cost-effectiveness of Universal BRCA1/2 Screening: Evidence-Based Decision Making.Semantic proximity Read ↗

Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review.Semantic proximity Read ↗

Genetic counseling program in familial breast cancer: analysis of its effectiveness, cost and cost-effectiveness ratio.Semantic proximity Read ↗

Developing national guidance on genetic testing for breast cancer predisposition: the role of economic evidence?Semantic proximity Read ↗

Mutation detection in the breast cancer gene BRCA1 using the protein truncation test.Semantic proximity Read ↗

Genomic profile of breast cancer: cost-effectiveness analysis from the Spanish National Healthcare System perspective.Semantic proximity Read ↗

Genetic screening by DNA technology: a systematic review of health economic evidence.Semantic proximity Read ↗

Dihydropyrimidine Dehydrogenase Deficiency (DPYD) Genotyping-Guided Fluoropyrimidine-Based Adjuvant Chemotherapy for Breast Cancer. A Cost-Effectiveness AnalysisSemantic proximity Read ↗

Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations.Semantic proximity Read ↗

Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia.Semantic proximity Read ↗

A fluorescent multiplex-DGGE screening test for mutations in the BRCA1 gene.Semantic proximity Read ↗

Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.